TVGNW — Tevogen Bio Holdings Inc.

Open full analysis

Chart, dilution, float and news for TVGNW in the TickerWise workspace.

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NASDAQ
• Employees: 18
• Website: https://tevogen.com

Latest SEC filings for TVGNW

• 2026-08-24S-8
• 2026-07-10S-8
• 2026-06-26EFFECT
• 2026-06-12S-3
• 2026-02-258-K
• 2026-01-308-K
• 2025-11-1410-Q
• 2025-11-14424B3
• 2025-09-26424B3
• 2025-09-268-K

Open full analysis

Educational tool only — not investment advice.